Department of Nephrology, The Second Xiangya Hospital at Central South University, Changsha, China.
Ren Fail. 2022 Dec;44(1):293-303. doi: 10.1080/0886022X.2022.2039194.
Diabetes kidney disease (DKD) affects approximately one-third of diabetes patients, however, the specific molecular mechanism of DKD remains unclear, and there is still a lack of effective therapies. Here, we demonstrated a significant increase of microRNA-122-5p (miR-122-5p) in renal tubular cells in STZ induced diabetic nephropathy (DN) mice. Moreover, inhibition of miR-122-5p led to increased cell death and serve tubular injury and promoted DN progression following STZ treatment in mice, whereas supplementation of miR-122-5p mimic had kidney protective effects in this model. In addition, miR-122-5p suppressed the expression of factor inhibiting hypoxia-inducible factor-1 (FIH-1) models of DN. microRNA target reporter assay further verified FIH-1 as a direct target of miR-122-5p. Generally, FIH-1 inhibits the activity of HIF-1α. Our study further indicated that overexpression of HIF-1α by transfection of HIF-1α plasmid reduced tubular cell death, suggesting a protective role of HIF-1α in DN. Collectively, these findings may unveil a novel miR-122-5p/FIH-1/HIF-1α pathway which can attenuate the DN progression.
糖尿病肾病(DKD)影响约三分之一的糖尿病患者,然而,DKD 的具体分子机制仍不清楚,并且仍然缺乏有效的治疗方法。在这里,我们在 STZ 诱导的糖尿病肾病(DN)小鼠的肾小管细胞中观察到 microRNA-122-5p(miR-122-5p)显著增加。此外,抑制 miR-122-5p 导致细胞死亡增加和肾小管损伤,并促进 STZ 处理后 DN 的进展,而在该模型中补充 miR-122-5p 模拟物具有肾脏保护作用。此外,miR-122-5p 抑制了 DN 模型中因子抑制低氧诱导因子-1(FIH-1)的表达。microRNA 靶标报告测定进一步证实了 FIH-1 是 miR-122-5p 的直接靶标。一般来说,FIH-1 抑制 HIF-1α 的活性。我们的研究进一步表明,通过 HIF-1α 质粒转染过表达 HIF-1α 可减少肾小管细胞死亡,提示 HIF-1α 在 DN 中具有保护作用。总之,这些发现可能揭示了一种新的 miR-122-5p/FIH-1/HIF-1α 通路,可减轻 DN 的进展。